| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥25.8B | ¥24.2B | +6.5% |
| Operating Income | ¥-2.4B | ¥1.2B | +298.0% |
| Ordinary Income | ¥-2.5B | ¥1.1B | +394.2% |
| Net Income | ¥-2.4B | ¥1.1B | +398.7% |
| ROE | -78.9% | 20.6% | - |
FY2026 Q2 results show revenue of 25.8B yen (YoY +6.5%), but the company recorded an operating loss of -2.4B yen (deteriorated from +1.2B yen profit in prior year), ordinary loss of -2.5B yen (from +1.1B yen), and net loss of -2.4B yen (from +1.1B yen). Despite maintaining revenue growth momentum, the quarter marked a significant reversal from profitability to loss-making, primarily driven by elevated selling, general and administrative expenses totaling 14.2B yen against gross profit of 11.7B yen. The gross profit margin remains healthy at 45.4%, but SG&A expenses representing 54.8% of revenue resulted in negative operating margin of -9.5%. Basic EPS declined to -29.43 yen from +13.98 yen YoY, reflecting the substantial loss.
Revenue increased 1.6B yen (YoY +6.5%) to 25.8B yen, maintaining moderate growth trajectory. Cost of sales rose to 14.1B yen, yielding gross profit of 11.7B yen with a healthy gross margin of 45.4%, indicating the core business model retains pricing power and margin quality. However, the profit decline was driven by SG&A expenses of 14.2B yen (54.8% of revenue), which exceeded gross profit by 2.5B yen. Within SG&A, advertising expenses of 5.4B yen represent the largest component, suggesting aggressive customer acquisition investment, while salaries of 2.2B yen reflect ongoing operational headcount. The SG&A burden increased faster than revenue growth, creating operating leverage reversal. Non-operating expenses of 0.1B yen (primarily interest expense of 0.1B yen on interest-bearing debt of 16.5B yen) were modest. Extraordinary income of 0.1B yen provided minor offset but was insufficient to materially alter profitability. The result represents a revenue up/profit down pattern, where top-line growth continued but bottom-line deteriorated sharply due to cost structure expansion outpacing revenue gains.
[Profitability] ROE of -78.9% reflects severe earnings deterioration combined with sharply reduced equity base. Operating margin of -9.5% (deteriorated from +5.1% YoY based on operating income change) indicates current cost structure exceeds revenue generation capacity. Net profit margin of -9.4% confirms loss-making status. Gross margin of 45.4% remains structurally sound, suggesting business model viability if SG&A can be controlled. [Cash Quality] Cash and deposits of 6.7B yen declined 4.2B yen (-38.5%) YoY due to large capital expenditures. Cash coverage of short-term debt stands at 0.89x (cash 6.7B yen vs. short-term borrowings 7.5B yen), indicating limited liquidity buffer. Operating cash flow of 2.3B yen against net loss of -2.4B yen yields OCF/net income ratio of -0.96x, raising earnings quality concerns. [Investment Efficiency] Asset turnover of 0.93x shows moderate asset utilization. CapEx of 7.2B yen versus depreciation of 3.6B yen yields CapEx/D&A ratio of 2.01x, indicating aggressive growth investment phase. [Financial Health] Equity ratio of 11.1% (down from 19.9% YoY) is critically low, with total equity of 3.1B yen compressed by accumulated losses. Current ratio of 83.3% (below 100% threshold) signals liquidity stress. Debt-to-equity ratio of 8.00x reflects extreme leverage, with interest-bearing debt of 16.5B yen comprising short-term borrowings of 7.5B yen and long-term loans of 9.0B yen. Retained earnings of -6.3B yen (negative and expanding) indicates sustained capital erosion.
Operating cash flow of 2.3B yen (YoY -56.1% from 5.3B yen) reflects deteriorated cash generation despite positive operating activities. Operating CF of 2.3B yen against net loss of -2.4B yen yields OCF/net income ratio of -0.96x, indicating non-cash adjustments (depreciation of 3.6B yen) supported cash generation while underlying earnings were negative. Working capital movements show inventory increase of 0.4B yen and receivables increase of 0.3B yen as cash outflows, partially offset by payables increase of 0.2B yen. Investing cash flow of -7.7B yen was dominated by capital expenditures of 7.2B yen, representing significant facility or infrastructure investment. This level of CapEx at 2.01x depreciation signals expansion phase but strains cash resources. Financing cash flow of 1.2B yen provided net inflow, likely reflecting borrowing activity to fund operations and investments. Free cash flow of -5.4B yen (operating CF 2.3B yen minus investing CF 7.7B yen) is deeply negative, indicating the company is consuming cash to fund growth investments. Cash and deposits declined 4.2B yen YoY to 6.7B yen, with short-term borrowings increasing 1.8B yen to 7.5B yen and long-term loans increasing 3.4B yen to 9.0B yen, illustrating debt-funded investment strategy under cash consumption pressure.
Ordinary loss of -2.5B yen versus operating loss of -2.4B yen shows non-operating net expense of approximately 0.1B yen, primarily consisting of interest expense of 0.1B yen on debt. Non-operating items are minimal and recurring in nature, representing approximately 0.4% of revenue, thus not materially distorting core business performance. Extraordinary income of 0.1B yen provided minor one-time benefit but insufficient to alter loss profile. The absence of significant non-recurring gains or impairments suggests reported losses reflect underlying business economics. Operating cash flow of 2.3B yen remains positive and represents -0.96x of net income, indicating cash generation exists despite accounting losses, though the cash conversion ratio of 1.22x (OCF divided by net income, adjusted for absolute values) is within acceptable range. However, the negative OCF trend (down 56.1% YoY) and growing divergence between operating profit and cash flow warrant monitoring. With operating CF subtotal before working capital changes at 2.4B yen and depreciation of 3.6B yen, the underlying EBITDA of approximately 1.1B yen is positive, suggesting operational cash generation capability exists beneath reported losses, though sustainability depends on SG&A efficiency improvements.
Against full-year guidance of revenue 57.2B yen, operating income 0.8B yen, ordinary income 0.5B yen, and net income 0.4B yen, Q2 actual results show revenue of 25.8B yen representing 45.1% progress, operating loss of -2.4B yen, ordinary loss of -2.5B yen, and net loss of -2.4B yen. Revenue progress of 45.1% at H1 is slightly below the standard 50% benchmark, suggesting modest first-half weighting or execution lag. However, profitability progress is deeply negative, with H1 operating loss of -2.4B yen requiring second-half operating income of approximately 3.2B yen to achieve full-year operating income guidance of 0.8B yen. This implies a dramatic H2 recovery scenario with operating margin shift from -9.5% in H1 to approximately +10% in H2, requiring significant SG&A reduction or revenue acceleration. The company has not revised guidance this quarter, indicating management maintains confidence in second-half improvement, likely predicated on customer acquisition investments in H1 yielding revenue benefits and operating leverage in H2. Key assumptions center on seasonality, marketing efficiency improvements, and cost control execution. The wide gap between H1 losses and full-year profit guidance presents execution risk and warrants close monitoring of Q3 trajectory.
The company maintains zero dividend policy with annual dividend forecast of 0.00 yen per share for FY2026, consistent with prior periods. No dividend revision occurred this quarter. Given net loss of -2.4B yen and negative retained earnings of -6.3B yen, dividend capacity is absent. Free cash flow of -5.4B yen further confirms no cash generation available for shareholder returns. Payout ratio is not calculable given negative earnings. No share buyback activity is disclosed. The company is prioritizing capital preservation and reinvestment over shareholder distributions, appropriate given current loss-making status and liquidity constraints. Return to dividend payments would require sustained return to profitability, positive free cash flow generation, and balance sheet repair.
Liquidity and refinancing risk given current ratio of 83.3% below 100% threshold and cash coverage of short-term debt at 0.89x. Short-term borrowings of 7.5B yen (45.5% of total liabilities) require refinancing or repayment within 12 months against declining cash position of 6.7B yen. Debt covenant breach or refinancing difficulty could trigger financial distress.
SG&A cost structure sustainability with expenses at 54.8% of revenue significantly exceeding gross profit. Advertising expense of 5.4B yen represents 20.9% of revenue; if customer acquisition efficiency deteriorates or lifetime value assumptions prove optimistic, ongoing losses and cash burn may persist beyond H1.
Capital investment return uncertainty with CapEx of 7.2B yen (2.01x depreciation) deployed in loss-making environment. Property, plant and equipment increased 2.9B yen to 13.1B yen. If investments fail to generate anticipated returns or market conditions deteriorate, asset impairment and further capital erosion may result. Debt/EBITDA of 14.4x (debt 16.5B yen / trailing EBITDA approximately 1.1B yen) significantly exceeds sustainable levels.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE -78.9% materially underperforms industry median of 5.6%, placing the company in severe distress territory. Operating margin of -9.5% substantially trails industry median of 14.0% (IQR: 3.8%-18.5%), indicating cost structure challenges unique to the company rather than sector-wide conditions. Net profit margin of -9.4% compares unfavorably to industry median of 9.2% (IQR: 1.1%-14.0%).
Financial Health: Equity ratio of 11.1% is critically below industry median of 60.2% (IQR: 50.8%-88.4%), reflecting extreme leverage and capital erosion. Current ratio of 0.83x is far below industry median of 7.74x (IQR: 3.16x-8.09x), signaling acute liquidity constraints relative to peers.
Efficiency: Asset turnover of 0.93x is substantially higher than industry median of 0.35 (IQR: 0.29-0.37), suggesting intensive asset utilization, though this has not translated to profitability. CapEx/D&A ratio of 2.01x significantly exceeds industry median of 0.34 (IQR: 0.24-1.70), confirming aggressive investment posture.
Growth: Revenue growth of 6.5% lags industry median of 21.0% (IQR: 15.5%-26.8%), indicating slower growth while incurring higher costs. The company's Rule of 40 score (revenue growth + operating margin) is approximately -3% versus industry median of 31% (IQR: 20%-51%), highlighting underperformance on both growth and profitability dimensions.
※ Industry: IT/Telecom (7 companies), Comparison: FY2025 Q2, Source: Proprietary analysis
Revenue growth of 6.5% continues but is overshadowed by structural cost burden with SG&A at 54.8% of revenue exceeding 45.4% gross margin, creating inherent negative operating leverage. The company requires substantial SG&A efficiency improvement or revenue acceleration to return to profitability, with H2 guidance implying operating margin shift of approximately 20 percentage points.
Aggressive capital deployment of 7.2B yen CapEx (2.01x depreciation) during loss-making period indicates growth investment strategy, but has compressed cash position by 38.5% YoY to 6.7B yen and elevated leverage to 8.00x debt-to-equity. Investment returns must materialize in near term to validate capital allocation and avoid balance sheet deterioration.
Critical liquidity position with current ratio below 1.0x at 83.3%, cash coverage of short-term debt at 0.89x, and 45.5% of liabilities maturing within 12 months creates refinancing dependency. Successful execution of H2 profit recovery and working capital management are essential to maintain financial flexibility and avoid covenant or liquidity constraints.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.